ESG

The B Corp lender's record year reveals a surge in demand for energy upgrades and a deep commitment to making green tech accessible to lower-income families.

With two strategic hires, Karoo Health signals a major push to dominate the value-based cardiac care market through tech innovation and national expansion.

Hawaiian beverage company Waiākea rolls out the world's first carbon-negative algae ink on its bottles, an open-source move to transform the industry.

At Expo West, GELITA unveils advanced collagen solutions, including OPTIBAR®, tackling major challenges in the booming high-protein, low-sugar snack market.

With promising preclinical data and Australian trial approval, Kivu’s KIVU-305 aims to overcome past failures in targeting aggressive solid tumors.

New subgroup data from ITM's COMPETE trial could refine treatment for a tough-to-treat cancer and bolster the company's position in the radiopharma market.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

Strategic Resources navigates a key environmental review for its iron ore pellet plant, tapping into Quebec's hydro power for the global green steel market.

After a breakout first year, Maine's sustainable canned water brand is expanding into Boston and Florida, leveraging its pure origins and a veteran sales team.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

Flush with cash and nearing major clinical milestones for its neuromuscular disease pipeline, Dyne Therapeutics is set to make its case to investors.

As Aura presents its precision oncology pipeline at key conferences, investors will weigh the promise of its lead drug against a challenging financial landscape.

With its new HAE drug EKTERLY® smashing revenue forecasts, KalVista heads to key conferences where investors will scrutinize its path to profitability.

Rise Wellness launches its new 30g carbonated protein drink at Costco, betting on fizz and function to capture a rapidly growing, competitive market.

With its stock lagging, TScan Therapeutics will use a key conference to highlight upcoming clinical trial data and convince investors of its pipeline's value.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

A landmark partnership aims to bring precision cancer therapy, or Theranostics, to millions in underserved nations, backed by a major WHO resolution.

A new partnership will integrate 150 million medical images into Verily's AI platform, aiming to accelerate health research and democratize discovery.

A new partnership between Salience Labs and Tower Semiconductor aims to mass-produce optical switches, a critical technology for faster, greener AI data centers.